FedEx has launched FedEx Life Sciences , a dedicated organization to support the increasingly complex movement of pharmaceuticals, medical devices, biologics, clinical trials and other critical healthcare shipments.
FedEx has also expanded its life sciences footprint with six Life Sciences Centers globally and has launched a direct flight between Indianapolis and Dublin to strengthen links between two pharmaceutical manufacturing hubs.
FedEx Life Sciences will include a dedicated healthcare team and advanced monitoring capabilities, headed by Nick Gennari who will exclusively focus on this segment as president of healthcare and life sciences. He joined FedEx in 1992, driving strategic sales and supply chain solutions for global healthcare, aerospace, and high-tech customers, before assuming leadership of the healthcare vertical in 2024.
FedEx has already made major investments in healthcare infrastructure and technology, securing IATA CEIV Pharma Corporate Certification in 2025 and achieving corporate-level certification for ground handling across its air hubs and ramps. It also recently appointed a vice president of global quality, healthcare, and life sciences to oversee global quality management systems and support the standards required by pharmaceutical and medical device manufacturers.
Executive vice president and chief customer officer, Brie Carere, said: “FedEx Life Sciences brings together our global network, advanced monitoring capabilities, and healthcare-focused expertise to help make supply chains smarter and more resilient. Under Nick’s leadership, this organization will help healthcare customers move with the speed, confidence, and precision patients require.”
